Levofloxacin Ibigen

Levofloxacin, the active ingredient in Levofloxacin Ibigen, is a fluoroquinolone antibiotic presented as an intravenous solution for systemic use. It treats a range of bacterial infections, including community‑acquired and hospital‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, and septicemia in adult patients.

GNH USA supplies Levofloxacin Ibigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat serious bacterial infections affecting various organ systems.

Community‑acquired pneumonia: effective eradication of typical and atypical pathogens in adult patients. Hospital‑acquired pneumonia: targets resistant Gram‑negative and Gram‑positive organisms. Complicated urinary tract infections: clears infections caused by susceptible Enterobacteriaceae. Skin and soft tissue infections: resolves cellulitis and wound infections caused by susceptible bacteria. Septicemia: provides rapid bactericidal activity in systemic bloodstream infections.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea or vomiting - Diarrhea or abdominal pain - Headache or dizziness - Rash or pruritus - Insomnia or sleep disturbances - Elevated liver enzymes

Serious or Rare Side Effects: - Tendon rupture or tendinitis, especially in the Achilles tendon - QT interval prolongation leading to arrhythmias - Clostridioides difficile‑associated colitis - Severe allergic reactions such as anaphylaxis - Hepatotoxicity with jaundice - Central nervous system effects including seizures or hallucinations

Levofloxacin should be used with caution in specific clinical situations.

Renal function: adjust dosing in patients with impaired renal clearance. History of tendon disorders: avoid in individuals with recent tendon injury or surgery. QT prolongation: monitor ECG in patients with cardiac risk factors. Concurrent NSAIDs: increased risk of central nervous system side effects. Pregnancy and lactation: prescribe only when benefits outweigh potential risks. Store at below 25°C: keep in the original container, protect from moisture and light.

Levofloxacin can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: additive toxicity. - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may potentiate anticoagulant effect and increase bleeding risk. - QT‑prolonging agents (e.g., macrolides, antiarrhythmics): heightened risk of arrhythmias.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may increase central nervous system adverse effects. - Corticosteroids: higher incidence of tendon rupture. - Theophylline: levofloxacin can raise plasma theophylline concentrations, requiring monitoring.